Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Rev Med Interne ; 29(2): 115-21, 2008 Feb.
Artigo em Francês | MEDLINE | ID: mdl-17976871

RESUMO

PURPOSE: During the past ten years, more than 1000 patients suffering from severe autoimmune disease have received an autologous haematopoietic stem cell transplant. These new therapeutic have been used in systemic sclerosis (scleroderma), multiple sclerosis, rheumatoid arthritis, juvenile idiopathic arthritis and systemic lupus erythematosus. CURRENT KNOWLEDGE AND KEY POINTS: Autologous haematopoietic stem cell transplantation has become a curative option for condition with very poor prognosis as severe systemic sclerosis, lupus erythematosus or other systemic diseases. This review summarizes the current experience in the phase I and II clinical trials in Europe and North America. We describe the main results and the limits of stem cell transplantation in systemic diseases. FUTURE PROSPECTS AND PROJECTS: Autologous haematopoietic stem cell transplant in the treatment of autoimmune disease has evolved from a experimental concept to a clinically feasible and powerful therapy for selected patients with severe disease.


Assuntos
Doenças Autoimunes/cirurgia , Transplante de Células-Tronco Hematopoéticas , Artrite Juvenil/cirurgia , Artrite Reumatoide/cirurgia , Ensaios Clínicos Fase I como Assunto , Ensaios Clínicos Fase II como Assunto , Humanos , Lúpus Eritematoso Sistêmico/cirurgia , Esclerose Múltipla/cirurgia , Escleroderma Sistêmico/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA